Odyssey Health (ODYY) Other Non Operating Income (2021 - 2026)
Odyssey Health's (ODYY) quarterly Other Non Operating Income came in at $1.5 million in Q2 2026, up 2352370.31% year-on-year from N/an in Q2 2025, and up 14790.03% quarter-over-quarter from -$10249.0 in Q1 2026.
Odyssey Health (ODYY) Other Non Operating Income (2021 - 2026) Analysis & Trends
Odyssey Health's Other Non Operating Income history runs 6 years deep, the most recent figure standing at $1.5 million for Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 2352370.31% year-over-year to $1.5 million in Q2 2026; TTM through Apr 2026 was $1.5 million, a 1789527.71% increase from a year earlier, with the FY2025 full-year figure at -$10005.0, down 207.99% from the prior year.
- Other Non Operating Income grew to $1.5 million in Q2 2026 per ODYY's latest filing, from -$10249.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.5 million in Q2 2026 and bottomed at -$10249.0 in Q1 2026.
- The 5-year median for Other Non Operating Income is $65.0 (2023), against an average of $133020.7.
- Biggest YoY gain for Other Non Operating Income was 2352370.31% in 2026; the steepest drop was 9948.04% in 2026.
- Year by year, Other Non Operating Income stood at -$474.0 in 2022, then soared by 113.71% to $65.0 in 2023, then jumped by 86.15% to $121.0 in 2024, then slumped by 76.86% to $28.0 in 2025, then surged by 5376975.0% to $1.5 million in 2026.
- Per Business Quant, the three latest ODYY Other Non Operating Income figures stand at $1.5 million (Q2 2026), -$10249.0 (Q1 2026), and $28.0 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.51 Mn |
| Jan 31, 2026 | -10,249.00 |
| Oct 31, 2025 | 28.00 |
| Jul 31, 2025 | -9,969.00 |
| Apr 30, 2025 | 64.00 |
| Jan 31, 2025 | -102.00 |
| Jul 31, 2024 | 121.00 |
| Apr 30, 2024 | 186.00 |
| Jan 31, 2024 | 8,890.00 |
| Oct 31, 2023 | 65.00 |
| Jul 31, 2023 | 275.00 |
| Apr 30, 2023 | -79.00 |
| Jan 31, 2023 | 8,955.00 |
| Oct 31, 2022 | -474.00 |
| Jan 31, 2022 | 492,018.00 |
| Apr 30, 2021 | 50,000.00 |